Teicoplanin
- Generic Name
- Teicoplanin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C88H97Cl2N9O33
- CAS Number
- 61036-62-2
- Unique Ingredient Identifier
- 4U3D3YY81M
- Background
Teicoplanin is a glycopeptide antibiotic consisting of a mixture of several compounds, five major (named teicoplanin A2-1 through A2-5) and four minor (named teicoplanin RS-1 through RS-4). All teicoplanins share a same glycopeptide core, teicoplanin A3-1, but differ in the length and conformation of side chains attached to their β-D-glucosamine moiety.
- Indication
For the treatment of bacterial infections caused by susceptible microorganisms.
- Associated Conditions
- Angina Pectoris, Anginal Pain, Bacteremia, Bloodstream Infections (BSI), Bone and Joint Infections, Clostridium Difficile, Clostridium Difficile Infection (CDI), Community Acquired Pneumonia (CAP), Complicated Urinary Tract Infection, Infective Endocarditis (IE), Lower Respiratory Tract and Lung Infections, Non-complicated Skin and Soft Tissue Infections, Nosocomial Pneumonia, Peritonitis, Skin and Soft Tissue Infections (SSTIs), Urinary Tract Infection
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath